Abstract
The carboxyl terminus of Hsc70-interacting protein (CHIP), an E3 ubiquitin ligase, participates in many cellular processes such as protein degradation, trafficking, autophagy, apoptosis, and multiple signaling transductions. The mutant of CHIP (p.T246M) causes the spinocerebellar autosomal recessive 16 (SCAR16), a neurodegenerative disease characterized by spinocerebellar atrophy. Previous studies have shown that Wnt signaling and activity-regulated cytoskeleton-associated protein (Arc) play important roles in neurodegenerative diseases. However, the mechanisms by which CHIP regulates Wnt signaling and the stability of Arc that may affect SCAR16 are still unclear. We show that overexpression of CHIP promoted the activation of Wnt signaling, and enhanced the interaction between LEF1 and β-catenin through heightening the K63-linked polyubiquitin chains attached to LEF1, while the knockdown of CHIP had the opposite effect. Moreover, we verified that Wnt signaling was inhibited in the rat models of SCAR16 induced by the CHIP (p.T246M) mutant. CHIP also accelerated the degradation of Arc and regulated the interaction between Arc and GSK3β by heightening the K48- or K63-linked polyubiquitin chains, which further potentiated the interaction between GSK3β and β-catenin. Our data identify that CHIP is an undescribed regulator of Wnt signaling and Arc stability which may be related to the occurrence of SCAR16.
Similar content being viewed by others
Introduction
The carboxy-terminus of HSC70-interacting protein (CHIP), encoded by the STUB1 gene, is an E3 ubiquitin ligase containing a three tetratricopeptide repeat domains, and a U-box domain displaying E3 ubiquitination ligase activity which participates in many vital processes to modulate protein degradation, cell proliferation, metastasis, and tumor progression1. Previously, CHIP is reported to regulate the ubiquitination and degradation of RIPK3, PTEN, HIF1A, TRAF2/6, and Smad1/Smad4 to regulate multiple signal transductions like necroptosis, autophagy, apoptosis, NF-κB pathway, and TGF-β pathway2,3,4,5,6,7,8,9. It also interacts with Tau, Parkin, α-Synuclein, LRRK2, Ataxin1, and Ataxin3 which involve in the pathogenesis of various neurodegenerative diseases10,11,12,13,14,15. Other reports suggest that the mutant of CHIP (p.T246M) causes the spinocerebellar autosomal recessive 16 (SCAR16)16,17. SCAR16, also known as Gordon Holmes Syndrome, is a form of autosomal recessive spinocerebellar ataxia and accompanied by hypogonadism18,19. To date, there is no clinically effective treatment of SCAR16. Therefore, it remains to be fully elucidated of the detailed pathogenic mechanism of SCAR16 caused by CHIP (p.T246M) mutant.
The canonical Wnt signaling pathway plays important role in embryo development, tumorigenesis, and the occurrence of neurodegenerative diseases20,21. In the absence of Wnt ligand, β-catenin is tightly regulated by the adenomatous polyposis (APC), AXIN, casein kinase 1 (CK1), glycogen synthase kinase 3 (GSK3β), and β-TrCP. When Wnt glycoprotein ligands binding to Frizzled transmembrane receptors and LDL receptor-related protein 6 (LRP6), β-catenin is stabilized and translocated to the nucleus where it forms a complex with lymphoid enhancer factor (LEF1), then activates the transactivation of Wnt target genes such as Myc, CyclinD1, and Axin2. The dysregulation of Wnt signaling can lead to the onset and development of neurodegenerative diseases, such as Alzheimer’s, Parkinson’s, and Huntington22. However, whether CHIP participates in the regulation of Wnt signaling and further influences the occurrence of SCAR16 remains to be resolved.
Activity-regulated cytoskeleton-associated protein (Arc) emerges as an immediate-early gene that participates in various forms of synaptic plasticity. It has a significant effect on the formation of long-term memory and maintenance of neuronal circuit homeostasis relying on the endocytosis of AMPA-type glutamate receptors23. According to reports, RNF216 and Ube3a can tag Arc for ubiquitination and degradation relating to cognitive dysfunction24,25,26,27. GSK3α and GSK3β can catalyze Arc phosphorylation and degradation which further contribute to synaptic plasticity and the plasticity of dendritic spines28. These previous studies suggest that the instability of Arc may be related to cognitive disorders. Meanwhile, RNF216 is one of the pathogenic genes of SCAR1629, leading to a hypothesis that CHIP may regulate Wnt signaling and disturbs Arc stability which may affect the occurrence of SCAR16.
Here, our study identified that CHIP is a positive regulator of Wnt signaling and assists the degradation of Arc. We found that cytoplasmic β-catenin was reduced in the rat models of SCAR16 induced by the CHIP (p.T246M) mutant. Overexpression of CHIP increased the activation of Wnt signaling, and promoted β-catenin nucleus accumulation by enhancing the interaction between LEF1 and β-catenin through heightening the K63-linked ubiquitination of LEF1. Meanwhile, CHIP also influenced Arc stability by heightening its K48-linked ubiquitination, and altered the interaction of Arc-GSK3β-β-catenin complex by increasing Arc K63-linked ubiquitination. Therefore, our study discovers a previously unrecognized role of CHIP in the regulation of Wnt signaling and Arc stability which may be one of the pathogenic mechanisms of SCAR16.
Results
CHIP promotes the activation of Wnt signaling and the degradation of Arc
Recent studies have reported that CHIP (p.T246M) mutant results in the occurrence of SCAR1616,17. Because the Wnt signaling pathway has been reported to play important roles in the regulation of neurodegenerative diseases, we first detected the function of CHIP in the transduction of Wnt signaling. We transfected HEK293T cells with CHIP or CHIP T246M, and stimulated the cells with Wnt3a. As shown in Fig. 1A, CHIP increased the protein level of β-catenin and active-β-catenin, while CHIP T246M mutant hardly had any effect. CHIP significantly enhanced the protein level of β-catenin and active-β-catenin under the Wnt3a stimulation. Meanwhile, in real-time PCR assays, we found that CHIP increased the expression levels of Wnt target genes, such as Myc, Cyclin D1, and Axin2 (Fig. 1B). Then to detect whether endogenous CHIP had the same effect on the regulation of Wnt signaling, we generated three pairs of siRNAs specific for CHIP, two of which validly inhibited the expression of CHIP at protein and mRNA levels (Fig. 1C, D). Further analyses showed that knockdown of CHIP by siRNA significantly decreased the protein level of β-catenin (Fig. 1C), and reduced the mRNA levels of Wnt target genes in SHSY5Y cells (Fig. 1E). At last, we obtained two CHIP−/− HT22 cell lines and one CHIP−/− HEK293T cell line using the CRISPR/Cas9 system and validated CHIP knockout cell lines by western blotting and sequencing (Fig. S1A–D). We found that knockout of CHIP showed a similar function as the knockdown in Wnt signaling (Fig. 1F–H). In addition, we found knockout of CHIP inhibited the migration and proliferation of HT22 cells through wound healing assay and MTT assay (Fig. S1E–G). These results revealed that CHIP had the function of maintaining cell proliferation and migration. CHIP (p.T246M) mutant lost its E3 ligase function, which might decrease the activation of Wnt signaling leading to cerebellum atrophy. We finally confirmed that Wnt signaling was inhibited in the rat model of SCAR16 induced by CHIP T246M mutant, suggesting that CHIP mutant might trigger SCAR16 by attenuating the activation of Wnt signaling (Fig. 1I). What’s more, CHIP was more significantly enriched in neural cell lines and brain tissues, correlating with the occurrence of neurodegenerative diseases (Fig. S1H, I). Hence, these data implied that CHIP was involved in the regulation of Wnt signaling.
It has been reported that the pathogenesis of SCAR16 characterized by cognitive decline and dementia is also associated with Arc that is critical for synaptic plasticity and memory23. For example, RNF216, which is another pathogenic gene of SCAR16, could disrupt the ubiquitination and degradation of synaptic protein Arc25. As GSK3α and GSK3β participate in the phosphorylation and degradation of Arc correlating Arc with Wnt signaling28, therefore, we want to detect whether CHIP regulates the stability of Arc. We found that CHIP facilitated the degradation of Arc, which was in consistent with the function of RNF216, while CHIP T246M had a slight function (Fig. 1J). These results suggested that CHIP promoted the activation of Wnt signaling and degradation of Arc.
CHIP accelerates the nucleus accumulation of β-catenin
The nucleus translocation of β-catenin is an important characteristic in the activated Wnt signaling pathway. To investigate the role of CHIP in Wnt pathway, we detected the protein level of β-catenin in nuclear. We transfected HEK293T cells with plasmids of CHIP WT or CHIP T246M, stimulated cells with Wnt3a, and then detected the abundance of β-catenin in cytosolic and nuclear fractions by immunoblotting. CHIP accelerated the nucleus translocation of β-catenin, while CHIP T246M had a reduced function (Fig. 2A). In the Wnt3a-treated CHIP−/−−1 HT22 cell, we found the protein level of β-catenin was reduced in the nuclear fraction (Fig. 2B). To further determine whether CHIP accelerates the nucleus accumulation of β-catenin, we processed CHIP and detected β-catenin in the nucleus by fluorescence analysis. The results showed that overexpression of CHIP increased the nucleus β-catenin, nevertheless the knockdown or knockout of CHIP decreased the amount of β-catenin in the nucleus (Fig. 2C, D). Thus, these data indicated that CHIP enhanced the nucleus accumulation of β-catenin.
CHIP interacts with LEF1 and Arc
Next, we sought to determine the detailed molecular mechanisms by which CHIP potentiates the activation of Wnt signaling. Firstly, we predicted the protein-protein interactions between CHIP and Arc or the downstream proteins of Wnt pathway by ZDOCK server. As shown in Table 1, CHIP might have strong interactions with Arc, β-Trcp, LEF1, or GSK3β. Co-immunoprecipitation assays (IP) revealed that CHIP specifically interacted with LEF1, Arc, and GSK3β, but had weak interactions with others (Fig. 3A). We have shown that CHIP promoted the activation of Wnt signaling by heightening the β-catenin nucleus accumulation, and had the strongest interaction with LEF1. It has been reported that LEF1 assists β-catenin to enter the nucleus and mediates the nuclear retention of β-catenin induced by Wnt3a30. So we focused on the interactions between CHIP and Arc or LEF1 instead of GSK3β. To identify the domains of CHIP responsible for the interaction with LEF1 or Arc, we expressed three CHIP deletion mutant proteins (Fig. 3B). CHIP could not interact with LEF1 or Arc after deleting the TPR domain (Fig. 3C, D), which suggested that the TPR domain of CHIP is essential for binding to LEF1 or Arc. Collectively, CHIP interacted with LEF1 or Arc, and its TPR domain was critical to the interactions.
CHIP increases the K63-linked ubiquitination of LEF1 and the K48-linked ubiquitination of Arc
CHIP is an E3 ligase enzyme that consists of a TPR domain, a coiled-coil domain, and a U Box domain responsible for E3 ligase enzyme activity. So we next test whether CHIP affects the ubiquitination of LEF1. As showed in Fig. 4A, B, CHIP markedly enhanced the ubiquitination of LEF1, while knockdown of CHIP reduced the ubiquitination of LEF1. And we further found the enzymatically inactive mutant CHIP T246M or CHIP TPR-CC slightly or rarely enhanced the ubiquitination of LEF1 (Fig. 4C). We then examined which kinds of ubiquitination of LEF1 might be affected by CHIP. Overexpression of CHIP markedly enhanced the K63-linked ubiquitination of LEF1, but had little or no effect on the K6, K11, K27, K29, K33, or K48-linked ubiquitination (Fig. 4D). Consistent with this result, the knockdown of CHIP limited the K63-linked ubiquitination of LEF1 (Fig. 4E). These results indicated that CHIP potentiated the K63-linked ubiquitination of LEF1 through its E3 ligase activity.
Then we detect whether CHIP can affect the degradation of Arc via influencing Arc ubiquitination. The results showed that CHIP could enhance the ubiquitination of Arc, while the CHIP T246M and CHIP TPR-CC mutants had a reduced function (Fig. 4F). CHIP further markedly potentiated the K48-linked ubiquitination of Arc, and weakly enhanced the K63-linked ubiquitination, but not others (Fig. 4G). In addition, we confirmed this finding with CHIP-specific siRNA (Fig. 4H). These results indicated that CHIP promotes the degradation of Arc by heightening K48-linked ubiquitination of Arc, and also influenced the signal transduction by increasing the K63-linked ubiquitination of Arc.
CHIP influences the interactions between β-catenin and LEF1 or GSK3β, as well as GSK3β and Arc
We have found that CHIP targeted and enhanced K63-linked ubiquitination of LFF1. Therefore, we want to know whether CHIP influences the interaction between LEF1 and β-catenin which then promotes Wnt signaling cascade. As shown in Fig. 5A, B, CHIP enhanced the interaction between β-catenin and LEF1, and the interaction was further heightened after Wnt3a treatment, while knockdown of CHIP decreased the interaction (Fig. 5C). Moreover, overexpression of CHIP T246M mutant couldn’t affect the interaction of β-catenin-LEF1 complex (Fig. 5D). To illuminate whether the heightened interaction of β-catenin and LEF1 was owing to the function of Wnt3a treatment in Fig. 5A, we detected the interaction between β-catenin and LEF1 as shown in Fig. 5D. Under Wnt3a stimulation, the interaction between β-catenin and LEF1 was enhanced, and the interaction was more strengthened with the presence of CHIP. We further found CHIP increased the endogenous interaction between β-catenin and LEF1, while CHIP T246M hardly influenced the interaction (Fig. 5E). Knockdown of CHIP reduced the endogenous interaction between β-catenin and LEF1 (Fig. 5F). These data suggested that CHIP enhanced the interaction between β-catenin and LEF1, and the interaction was further heightened with Wnt3a treatment.
It has been reported that Arc is phosphorylated, ubiquitinated, and subsequently degraded in GSK3α/β-dependent manner28. We hypothesized that CHIP participated in the degradation of Arc after GSK3β-mediated phosphorylation. Immunoprecipitation analysis revealed that CHIP reduced the interaction between Arc and GSK3β which might be convenient for the interaction of Arc and CHIP (Fig. 5G). Meanwhile, we found CHIP accelerated the interaction between GSK3β and β-catenin, which was associated with the activation of Wnt signaling (Fig. 5H). After the stimulation of Wnt3a, the interaction of Arc-GSK3β was enhanced, while the interaction of GSK3β and β-catenin decreased (Fig. 5G, H). It was in consistent with the enhanced interaction between β-catenin and LEF1 after Wnt3a treatment. Taken together, CHIP acts as a cargo to regulate Wnt signaling and the degradation of Arc by influencing the interactions between β-catenin and LEF1 or GSK3β, as well as GSK3β and Arc.
Discussion
CHIP plays important role in cerebella homeostasis, cell proliferation, and tumor progression. It has been reported that the mutant of CHIP (p.T246M) lose E3 ligase activity, but maintains the features of the interactions with chaperones and chaperone-related functions which may lead to the occurrence of SCAR1616,17. But the detailed pathogenic mechanisms are still not clear.
Wnt signaling is an evolutionarily conserved pathway that controls multiple biological processes in embryonic and adult life. Growing evidences indicate that the dysregulation of Wnt signaling play a critical role in neurodegenerative diseases onset and development22. It has been reported that one of the pathogenesis of Alzheimer and Parkinson are the inactivation of Wnt signaling by regulating the activation of GSK3β or high leveled DKK131,32,33,34. Although the role of CHIP in Wnt signaling may be related to the occurrence of SCAR16, the detailed regulatory mechanisms still needed to be studied. Our results showed that CHIP increases the protein level of β-catenin and active-β-catenin, enhances the expression of Wnt target genes, and further accelerates the nucleus accumulation of β-catenin detected by immunoblotting and fluorescence analysis, while knockdown of CHIP has the opposite effect. Compared to the CHIP WT, CHIP (p.T246M) mutant loses the ability to activate Wnt signaling. Moreover, knockout of CHIP inhibits the activation of Wnt signaling which further depresses cell proliferation and migration. We also confirm that Wnt signaling is inactivated in the rat model of SCAR16 induced by CHIP T246M mutant. These results indicate that CHIP may promote the activation of Wnt signaling which further influences the occurrence of SCAR16.
The regulatory mechanisms of β-catenin nuclear accumulation have not yet been elucidated. There are mainly two aspects influencing the nuclear accumulation of β-catenin: the transport and the retention in the nucleus by interacting with the nuclear pore complex35,36, and some nuclear localization signal-containing proteins, including FoxM1, IRS-1, and Rac137,38,39, or Twa1/Gid8 or LEF1 which act as β-catenin nucleus retention factors in Wnt signaling30,40,41,42. Although they claim that LEF1 chaperones β-catenin into the nucleus is controversial, our data support that LEF1 facilitates β-catenin nuclear accumulation by increasing the nucleus retention. We demonstrate that CHIP can interact with LEF1, and markedly enhances the K63-linked ubiquitination of LEF1. The ubiquitinated LEF1 accelerates the interaction between β-catenin and LEF1, which is further heightened after Wnt3a treatment. Moreover, we verify that CHIP promotes the endogenous interaction between LEF1 and β-catenin, the CHIP (p.T246M) mutant does not affect the interaction, while knockdown of CHIP decreases the endogenous interaction of LEF1-β-catenin complex. Taken together, these results indicate that CHIP accelerates β-catenin nucleus accumulation by promoting interaction between LEF1 and β-catenin through heightening the K63-linked ubiquitination of LEF1.
Arc is dynamically regulated by neuronal activity serving as a master regulator of synaptic plasticity. It can regulate the endocytosis of synaptic AMPA receptors, which are involved in multiple forms of synaptic plasticity to influence learning-related behaviors by interacting with endosome-associated proteins like endophilin-2/3 and dynamin 223,43. The alterations of Arc may have a positive or negative impact on the learning-related plasticity, which ultimately implicate neurological disease such as dementia, psychiatric disorders, and neurodegenerative disorders. The missense mutants in RNF216 (R660C and R694C) abolish the interaction, ubiquitination, and degradation of Arc, which contribute to SCAR1625. In this study, we also discovered CHIP affects the stability of Arc. Overexpression of CHIP reduces the protein level of Arc, while CHIP T246M hardly plays any role. CHIP can also interact with Arc, and enhances the K48 and K63-linked ubiquitination of Arc, while the enzymatically inactive mutant CHIP T246M and CHIP TPR-CC do not affect the ubiquitination of Arc. Since GSK3α and GSK3β is reported to influence synaptic plasticity and the plasticity of dendritic spines through catalyzing Arc phosphorylation and degradation28, we detect the interaction between Arc and GSK3β. CHIP reduces the interaction between Arc and GSK3β which may be convenient for the interaction between Arc and CHIP, then promotes the K48-linked ubiquitination and degradation of Arc. CHIP also accelerates the interaction between GSK3β and β-catenin which may restrict the nucleus accumulation of β-catenin. After stimulation of Wnt3a, the interactions between GSK3β and Arc or β-catenin are altered, which may promote the activation of Wnt signaling. Taken together, CHIP may act as a cargo to regulate the transduction of Wnt signaling and the stability of Arc to influence the occurrence of SCAR16.
In conclusion, we demonstrate that CHIP promotes the activation of Wnt signaling and regulates the degradation of Arc. Thus, our findings uncover the previously unknown mechanism of CHIP in signaling transduction, and may gain an insight into the molecular mechanisms by which the mutant of CHIP (p.T246M) results in the occurrence of SCAR16.
Materials and methods
Reagents, antibodies, and plasmids
Recombinant Human Wnt-3a (NP-149122) was purchased from an R&D system (Minneapolis, MN, USA).
Horseradish peroxidase (HRP)-anti-Flag (M2) (A8592), anti-β-actin (A1978), anti-rabbit-IgG-HRP (AP132P), and anti-mouse-IgG-HRP (AP308P) were purchased from Sigma (St. Louis, MO, USA). HRP-anti-hemagglutinin (12013819001) was purchased from Roche Applied Science (Switzerland, Basel). anti-c-Myc (HT101) and anti-β-tubulin (HC101) were purchased from TransGen Biotech (Beijing, China). anti-β-Catenin (8480) and anti-non-phospho β-Catenin (19807) were purchased from Cell Signaling Technology (Danvers, MA, USA). anti-LMNB1 (101237-T32) and anti-STUB1 (12496-R034) were purchased from Sino Biological (Beijing, China). anti-LEF1 (sc-374522) and anti-Arc (sc-17839) were purchased from Santa Cruz Biotechnology (San Diego, CA, USA).
Empty vector pcDNA3.1 was kindly provided by Dr Jun Cui (Sun Yat-sen University, Guangzhou, China). Target genes were cloned from A549 cDNA and subcloned into the pcDNA3.1 vector. The plasmids were confirmed by DNA sequencing at Sangon Biotech (Shanghai, China).
Cell culture and transfection
Human embryonic kidney 293T (HEK293T) cells were kindly provided by Dr Jun Cui (Sun Yat-sen University). HT22 cells were kindly provided by Dr Fangxia Guan (Zhengzhou University). SHSY5Y cells were obtained from Cell Bank of the Chinese Academy of Sciences (Shanghai, China). L-Wnt3a cells were kindly provided by Dr Zongping Xia (The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China). The brain tissues from rat models of SCAR16 (32 weeks) induced by the CHIP (p.T246M) mutant and WT rats (32 weeks) were kindly provided by Dr Yuming Xu (The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China). These cells were cultured in DMEM (Hyclone, Logan, UT, USA) with 10% fetal bovine serum (BioIn, Israel), and 1% L-glutamine (Gibco, Carlsbad, CA, USA) at 37 °C in 5% CO2. Expression plasmids were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions.
Wnt3a conditioned medium (Wnt3a CM) was obtained by spilling L-Wnt3a cells at the density of 1:10 and culturing in 10 ml DMEM medium without G418 for 4 days, and the medium was collected and filtered. Then the cells needed to add 10 ml fresh DMEM medium and cultured for another 3 days. The first batch and second batch of medium were collected, filtered, mixed, and stored at 4 °C. Ctrl-CM was obtained from L cells as the above method.
Fluorescence analysis
HEK293T or HT22 cells were grown on coverslips, and then transfected with a green fluorescent protein (GFP)-tagged β-Catenin (β-Catenin-GFP) plus targeted plasmids or stimulated with ligands. The cells were stained with DAPI (Sigma) for 5 min. At last, the cells were fixed on the coverslips and observed under the fluorescence microscope (Olympus, Tokyo, Japan).
MTT and migration assays
For MTT assay, the cells were seeded in 96-well plates at a density of 2 × 103 cells per well for 24 h, and incubated with MTT (5 mg/ml, 20 μl) (Solarbio, Beijing, China) for 4 h, then added with 150 μl dimethyl sulfoxide (DMSO, Sigma). The absorbance of the samples was measured at 570 nm by Multiscan Spectrum (PerkinElmer EnSpire, USA).
For migration assay, the cells were seeded in 6-well plates at a density of 5 × 105 cells per well. The monolayer cells were scratched using a 200 μl pipette tip, and then incubated and observed using a microscope (Olympus) after indicated times. The distances between the edges of scratch were measured to evaluate the capability of cell migration.
Immunoblot analysis
Lysates from the transfected cells were extracted in 120 μl low-salt lysis buffer (50 mM Hepes pH 7.5, 150 mM NaCl, 1 mM EDTA, 1.5 mM MgCl2, 10% glycerol, 1% Triton X-100), supplemented with 5 mg/ml protease inhibitor (Thermo, Waltham, MA, USA) and phosphatase inhibitor Cocktail (Roche). The samples of 20 μl total proteins were subjected to SDS-PAGE and transferred onto PVDF membranes (Millipore, Schwalbach, Germany) with subsequent blocking using 5% skim milk (Solarbio). Membranes were incubated with specific antibodies, and detected using chemiluminescence (Millipore).
Cytosolic and nuclear fractions were obtained using MinuteTM Cytoplasmic and Nuclear Fractionation Kit for Cells (Invent Biotechnologies, Eden Prairie, MN, USA) according to the manufacturer’s instructions.
Immunoprecipitation analysis
For immunoprecipitation experiments, whole-cell lysates were prepared as the method of immunoblot assay, followed by incubation with the anti-Flag agarose gels (Sigma) overnight at 4 °C. The beads were washed five times with low-salt lysis buffer, and then resuspended with 2 × SDS Loading Buffer (Solarbio), and boiled for 10 min. The released proteins were subjected to western blot analyses with the indicated antibodies.
For endogenous immunoprecipitation experiments, the extracted cell proteins were incubated with indicated antibodies overnight at 4 °C, and added with 20 μl Dynabeads protein G (Invitrogen) for another 2 h. Then the beads were washed and subjected to western analyses with the indicated antibodies.
Real-time PCR
The total cellular RNA was isolated by TRIzol Reagent (Invitrogen) according to the manufacturer’s protocol. The first-strand cDNA was synthesized from total RNA using PrimeScript Frist Strand cDNA Synthesis kit (TAKARA, Otsu, Japan). Real-time PCR was performed with the SYBR Green qPCR Mix (TAKARA). Myc, Cyclin D1, and Axin2 were analyzed by RT-PCR at 94 °C for 5 min, followed by 40 cycles at 94 °C for 20 s, at 56 °C for 20 s, at 72 °C for 20 s. The following specific primers are used for real-time PCR which is designed and synthesized by Sangon Biotech.
hMyc forward primer, 5′-CTTCTCTCCGTCCTCGGATTCT-3′
hMyc reverse primer, 5′-GAAGGTGATCCAGACTCTGACCTT-3′
hCyclin D1 forward primer, 5′-AAGTGCGAGGAGGAGGTCTT-3′
hCyclin D1 reverse primer, 5′-GGATGGAGTTGTCGGTGTAGA-3′
hAxin2 forward primer, 5′-CCACCACTACATCCACCACC-3′
hAxin2 reverse primer, 5′-TGCCTTTCCCATTGCGTTTG-3′
hATCB forward primer, 5′-GTCACCAACTGGGACGACAT-3′
hATCB reverse primer, 5′-TAGCAACGTACATGGCTGGG-3′
mMyc forward primer, 5′-CCCTATTTCATCTGCGACGAG-3′
mMyc reverse primer, 5′-GAGAAGGACGTAGCGACCG-3′
mCyclin D1 forward primer, 5′-CCCTGGAGCCCTTGAAGAAG-3′
mCyclin D1 reverse primer, 5′-TCATCCGCCTCTGGCATTTT-3′
mAxin2 forward primer, 5′-AACCTATGCCCGTTTCCTCTA-3′
mAxin2 reverse primer, 5′-GAGTGTAAAGACTTGGTCCACC-3′
mATCB forward primer, 5′-ATATCGCTGCGCTGGTCG-3′
mATCB reverse primer, 5′-TGGGGTACTTCAGGGTCAGG-3′
Knockdown of CHIP by RNA interference
HEK293T or SHSY5Y were transfected with siRNAs using LipoRNAiMAX (Invitrogen) according to the manufacturer’s protocols. The sequences of STUB1 specific siRNAs are designed and synthesized by RiboBio as follows (Guangzhou, China).
#1 SenseSeq: CUGGAACAGUAUCGAGGAATT
AntiSeq: UUCCUCGAUACUGUUCCAGTT
#2 SenseSeq: CAACUUUGGGGAUGAUAUUTT
AntiSeq: AAUAUCAUCCCCAAAGUUGTT
#3 SenseSeq: GGAGAUGGAGAGUUAUGAUTT
AntiSeq: AUCAUAACUCUCCAUCUCCTT
Statistical analysis
Data were compared between the different test groups using an unpaired, two-tailed Student’s t-test by the GraphPad Prism 5.0 software. All the experiments were repeated at least three times independently and the differences between groups were considered significant if *P < 0.05, **P < 0.01, and ***P < 0.001.
References
Jiang, J. et al. CHIP is a U-box-dependent E3 ubiquitin ligase: identification of Hsc70 as a target for ubiquitylation. J. Biol. Chem. 276, 42938–42944 (2001).
Seo, J. et al. CHIP controls necroptosis through ubiquitylation- and lysosome-dependent degradation of RIPK3. Nat. Cell Biol. 18, 291–302 (2016).
Guo, D. et al. Regulation of autophagic flux by CHIP. Neurosci. Bull. 31, 469–479 (2015).
Ferreira, J. V. et al. STUB1/CHIP is required for HIF1A degradation by chaperone-mediated autophagy. Autophagy 9, 1349–1366 (2013).
Lv, Y., Song, S., Zhang, K., Gao, H. & Ma, R. CHIP regulates AKT/FoxO/Bim signaling in MCF7 and MCF10A cells. PLoS ONE 8, e83312 (2013).
Liu, F., Zhou, J., Zhou, P., Chen, W. & Guo, F. The ubiquitin ligase CHIP inactivates NF-kappaB signaling and impairs the ability of migration and invasion in gastric cancer cells. Int. J. Oncol. 46, 2096–2106 (2015).
Li, S. et al. Carboxyl terminus of Hsp70-interacting protein regulation of osteoclast formation in mice through promotion of tumor necrosis factor receptor-associated factor 6 protein degradation. Arthritis Rheumatol. 66, 1854–1863 (2014).
Li, L. et al. CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription. Mol. Cell. Biol. 24, 856–864 (2004).
Shang, Y. et al. Hsp70 and Hsp90 oppositely regulate TGF-beta signaling through CHIP/Stub1. Biochem. Biophys. Res. Commun. 446, 387–392 (2014).
Petrucelli, L. et al. CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation. Hum. Mol. Genet. 13, 703–714 (2004).
Imai, Y. et al. CHIP is associated with Parkin, a gene responsible for familial Parkinson’s disease, and enhances its ubiquitin ligase activity. Mol. Cell 10, 55–67 (2002).
Tetzlaff, J. E. et al. CHIP targets toxic alpha-Synuclein oligomers for degradation. J. Biol. Chem. 283, 17962–17968 (2008).
Ko, H. S. et al. CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity. Proc. Natl Acad. Sci. USA 106, 2897–2902 (2009).
Al-Ramahi, I. et al. CHIP protects from the neurotoxicity of expanded and wild-type ataxin-1 and promotes their ubiquitination and degradation. J. Biol. Chem. 281, 26714–26724 (2006).
Scaglione, K. M. et al. Ube2w and ataxin-3 coordinately regulate the ubiquitin ligase CHIP. Mol. Cell 43, 599–612 (2011).
Shi, C. H. et al. Ataxia and hypogonadism caused by the loss of ubiquitin ligase activity of the U box protein CHIP. Hum. Mol. Genet 23, 1013–1024 (2014).
Shi, C. H. et al. Disrupted structure and aberrant function of CHIP mediates the loss of motor and cognitive function in preclinical models of SCAR16. PLoS Genet. 14, e1007664 (2018).
Holmes, G. A form of familial degeneration of the cerebellum. Brain 30, 466–489 (1908).
Mehmood, S., Hoggard, N. & Hadjivassiliou, M. Gordon Holmes syndrome: finally genotype meets phenotype. Pr. Neurol. 17, 476–478 (2017).
Clevers, H. Wnt/beta-catenin signaling in development and disease. Cell 127, 469–480 (2006).
Moon, R. T., Kohn, A. D., De Ferrari, G. V. & Kaykas, A. WNT and beta-catenin signalling: diseases and therapies. Nat. Rev. Genet. 5, 691–701 (2004).
Libro, R., Bramanti, P. & Mazzon, E. The role of the Wnt canonical signaling in neurodegenerative diseases. Life Sci. 158, 78–88 (2016).
Newpher, T. M., Harris, S., Pringle, J., Hamilton, C. & Soderling, S. Regulation of spine structural plasticity by Arc/Arg3.1. Semin. Cell Dev. Biol. 77, 25–32 (2018).
Mabb, A. M. et al. Triad3A regulates synaptic strength by ubiquitination of Arc. Neuron 82, 1299–1316 (2014).
Husain, N. et al. TRIAD3/RNF216 mutations associated with Gordon Holmes syndrome lead to synaptic and cognitive impairments via Arc misregulation. Aging Cell 16, 281–292 (2017).
Greer, P. L. et al. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140, 704–716 (2010).
Kuhnle, S., Mothes, B., Matentzoglu, K. & Scheffner, M. Role of the ubiquitin ligase E6AP/UBE3A in controlling levels of the synaptic protein Arc. Proc. Natl Acad. Sci. USA 110, 8888–8893 (2013).
Gozdz, A. et al. GSK3alpha and GSK3beta phosphorylate Arc and regulate its degradation. Front Mol. Neurosci. 10, 192 (2017).
Margolin, D. H. et al. Ataxia, dementia, and hypogonadotropism caused by disordered ubiquitination. N. Engl. J. Med. 368, 1992–2003 (2013).
Huber, O. et al. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev. 59, 3–10 (1996).
Baki, L. et al. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 23, 2586–2596 (2004).
Rosi, M. C. et al. Increased Dickkopf-1 expression in transgenic mouse models of neurodegenerative disease. J. Neurochem 112, 1539–1551 (2010).
Lin, C. H., Tsai, P. I., Wu, R. M. & Chien, C. T. LRRK2 G2019S mutation induces dendrite degeneration through mislocalization and phosphorylation of tau by recruiting autoactivated GSK3ss. J. Neurosci. 30, 13138–13149 (2010).
Rawal, N. et al. Parkin protects dopaminergic neurons from excessive Wnt/beta-catenin signaling. Biochem. Biophys. Res. Commun. 388, 473–478 (2009).
Fagotto, F., Gluck, U. & Gumbiner, B. M. Nuclear localization signal-independent and importin/karyopherin-independent nuclear import of beta-catenin. Curr. Biol. 8, 181–190 (1998).
Jamieson, C., Sharma, M. & Henderson, B. R. Targeting the beta-catenin nuclear transport pathway in cancer. Semin. Cancer Biol. 27, 20–29 (2014).
Jamieson, C., Lui, C., Brocardo, M. G., Martino-Echarri, E. & Henderson, B. R. Rac1 augments Wnt signaling by stimulating beta-catenin-lymphoid enhancer factor-1 complex assembly independent of beta-catenin nuclear import. J. Cell Sci. 128, 3933–3946 (2015).
Zhang, N. et al. FoxM1 promotes beta-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis. Cancer Cell 20, 427–442 (2011).
Chen, J. et al. Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and beta-catenin. J. Biol. Chem. 280, 29912–29920 (2005).
Lu, Y. et al. Twa1/Gid8 is a beta-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis. Cell Res. 27, 1422–1440 (2017).
Asally, M. & Yoneda, Y. Beta-catenin can act as a nuclear import receptor for its partner transcription factor, lymphocyte enhancer factor-1 (lef-1). Exp. Cell Res. 308, 357–363 (2005).
Jamieson, C., Sharma, M. & Henderson, B. R. Regulation of beta-catenin nuclear dynamics by GSK-3beta involves a LEF-1 positive feedback loop. Traffic 12, 983–999 (2011).
Chowdhury, S. et al. Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron 52, 445–459 (2006).
Acknowledgements
This work was supported by the National Natural Science Foundation of China (31572353, 31970419, 81530037, 81471158), Scientific and Technological Innovation leaders in Central Plains (194200510002), and the Science and Technology Research Project of Henan (20210231015).
Author information
Authors and Affiliations
Contributions
Y.L. designed and performed experiments, analyzed data, and wrote this manuscript. Y.S., Y.H., and K.C. performed experiments and analyzed data. Y.X., Q.T., and S.Z. designed experiments, interpretation of the data, and revised the manuscript for intellectual content. In Fig. 1 and Fig. S1, Y.L., Y.H., and K.C. generated and analyzed the data, and Y.S. labeled the images and assembled the figure. In Fig. 2, Y.L. generated the data, labeled the images, and assembled the figure. Y.S. generated the fluorescence data. In Figs. 3, 4, and 5, Y.L. and Y.S. generated and analyzed the data, and Y.L. labeled the images and assembled the figures.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Edited by David Michod
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Liu, Y., Sun, Y., Huang, Y. et al. CHIP promotes Wnt signaling and regulates Arc stability by recruiting and polyubiquitinating LEF1 or Arc. Cell Death Discov. 7, 5 (2021). https://doi.org/10.1038/s41420-020-00394-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41420-020-00394-9
- Springer Nature Limited